Drug Design UCL

Overview

The Drug Design MSc at UCL is a one-year programme that provides a comprehensive introduction to modern drug discovery and design. The course explores how new medicines are identified and developed, combining biological, chemical, and computational approaches used in pharmaceutical research.

Why Drug Design at UCL?

The MSc in Drug Design at UCL is distinguished by its strong academic reputation and the expertise of its faculty, which includes leading researchers and industry professionals. UCL is renowned for its innovative approach to drug discovery, supported by cutting-edge facilities and partnerships within the pharmaceutical and biotechnology sectors. This programme not only offers a robust curriculum but also provides students with invaluable networking opportunities, enhancing their employability in a competitive job market.

Tuition Fee Breakdown

For the academic year 2026/27, the tuition fees for the MSc in Drug Design are as follows:

• National students: £18,400 per year
• International students: £36,500 per year

Visit the Fees and Funding section for a breakdown in your local currency.

Syllabus

The curriculum comprises eight core modules and a significant research project, allowing students to engage deeply with the subject matter. The modules include:

• Biological Molecules as Therapies
• Bioinformatics and Structural Biology as Applied to Drug Design
• The Biology of Drug Discovery Programmes 1
• Cheminformatics and Modelling for Drug Design
• Choosing a Drug Target 2: Intellectual Property, Clinical Need and Commercial Aspects
• The Biology of Drug Discovery Programmes 2: Latest Advances
• Fragment-Based Drug Design
• Choosing a Drug Target 1: Scientific and Technical Aspects

The research project, which lasts a minimum of three months, allows students to apply their knowledge in a practical setting, either in a laboratory or through computational methods.

Careers with Drug Design

Graduates of the Drug Design MSc programme are well-prepared for various roles in the pharmaceutical and biotechnology industries. Many alumni have progressed to prestigious PhD programmes or medical studentships at institutions such as Oxford and UCL. The HESA Graduate Outcomes survey indicates that 87% of graduates enter the workforce or pursue further studies, with a significant number securing positions in reputable organisations including NHS Trusts, clinical research entities, and pharmaceutical companies like Novo Nordisk. Graduates often take on roles such as biological scientists, laboratory technicians, and quality assurance professionals, contributing to advancements in drug discovery and development. The programme also emphasises the importance of networking, providing students with opportunities to connect with industry experts and participate in workshops that enhance their professional skills. The teaching methodology combines lectures, practical sessions, and independent study, ensuring a comprehensive educational experience that prepares students for the challenges of the drug design field.